• Explore /
  • Poster
  • / A phase II trial of an oral CDK 4/6 inhibitor, PD0332991, in advanced breast cancer.

A phase II trial of an oral CDK 4/6 inhibitor, PD0332991, in advanced breast cancer.

Abstract Poster

Authors

null

Angela DeMichele

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

Angela DeMichele , Amy Sanders Clark , Daniel Heitjan , Sophia Randolph , Maryann Gallagher , Priti Lal , Michael D Feldman , Paul J. Zhang , Allison Schnader , Kelly Zafman , Susan M. Domchek , Keerthi Gogineni , Stephen Michael Keefe , Kevin R. Fox , Peter J. O'Dwyer

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer - HER2/ER

Track

Breast Cancer

Sub Track

ER+

Clinical Trial Registration Number

NCT01037790

Citation

J Clin Oncol 31, 2013 (suppl; abstr 519)

DOI

10.1200/jco.2013.31.15_suppl.519

Abstract #

519

Poster Bd #

7

Abstract Disclosures

Similar Posters

First Author: Jifang Gong

Poster

2012 Breast Cancer Symposium

Sonodynamic and photodynamic therapy in advanced refractory breast cancer.

Sonodynamic and photodynamic therapy in advanced refractory breast cancer.

First Author: Xiaohuai Wang

First Author: Richard D. Kim

First Author: Ting Han